These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36850019)

  • 1. Whole-genome sequence analysis of clinically isolated carbapenem resistant Escherichia coli from Iran.
    Haeili M; Barmudeh S; Omrani M; Zeinalzadeh N; Kafil HS; Batignani V; Ghodousi A; Cirillo DM
    BMC Microbiol; 2023 Feb; 23(1):49. PubMed ID: 36850019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem and colistin-resistant bacteria in North Lebanon: Coexistence of mcr-1 and NDM-4 genes in Escherichia coli.
    Al-Bayssari C; Nawfal Dagher T; El Hamoui S; Fenianos F; Makdissy N; Rolain JM; Nasreddine N
    J Infect Dev Ctries; 2021 Jul; 15(7):934-342. PubMed ID: 34343118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran.
    Sharahi JY; Hashemi A; Ardebili A; Davoudabadi S
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):32. PubMed ID: 33906654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of carbapenem resistant Escherichia coli isolates producing bla
    Solgi H; Giske CG; Badmasti F; Aghamohammad S; Havaei SA; Sabeti S; Mostafavizadeh K; Shahcheraghi F
    Infect Genet Evol; 2017 Nov; 55():318-323. PubMed ID: 28987805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence and transmission of New Delhi metallo-beta-lactamase-5-producing Escherichia coli Sequence Type 361 in a Tertiary Hospital in South Korea.
    Park Y; Choi Q; Kwon GC; Koo SH
    J Clin Lab Anal; 2020 Feb; 34(2):e23041. PubMed ID: 31541503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissemination of an international high-risk clone of Escherichia coli ST410 co-producing NDM-5 and OXA-181 carbapenemases in Seoul, Republic of Korea.
    Kim JS; Yu JK; Jeon SJ; Park SH; Han S; Park SH; Kang M; Jang JI; Park J; Shin EK; Kim J; Hong CK; Lee JH; Hwang YO; Oh YH
    Int J Antimicrob Agents; 2021 Dec; 58(6):106448. PubMed ID: 34648943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurrence of genes encoding carbapenemase, ESBL, pAmpC and non-β-Lactam resistance among Klebsiella pneumonia and E. coli clinical isolates in Tunisia.
    Ben Sallem R; Laribi B; Arfaoui A; Ben Khelifa Melki S; Ouzari HI; Ben Slama K; Naas T; Klibi N
    Lett Appl Microbiol; 2022 May; 74(5):729-740. PubMed ID: 35076956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant
    El-Mahallawy HA; El Swify M; Abdul Hak A; Zafer MM
    Ann Med; 2022 Dec; 54(1):1-9. PubMed ID: 36373970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
    Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
    Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and genotypic characteristics of carbapenem resistant Enterobacterales in Henan, China: a multicentre study.
    Jing N; Yan W; Zhang Q; Yuan Y; Wei X; Zhao W; Guo S; Guo L; Gao Y; Zhao L; Shi C; Li Y
    J Glob Antimicrob Resist; 2022 Jun; 29():68-73. PubMed ID: 35134552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant
    Peng C; Feng DH; Zhan Y; Wang Q; Chen DQ; Xu Z; Yang L
    Microb Drug Resist; 2022 Jun; 28(6):698-709. PubMed ID: 35639427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
    Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
    Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam.
    Tada T; Tsuchiya M; Shimada K; Nga TTT; Thu LTA; Phu TT; Ohmagari N; Kirikae T
    BMC Infect Dis; 2017 Jul; 17(1):467. PubMed ID: 28676118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population genomic analysis reveals the emergence of high-risk carbapenem-resistant Escherichia coli among ICU patients in China.
    Zhang R; Li Y; Chen J; Liu C; Sun Q; Shu L; Chen G; Wang Z; Wang S; Li R
    J Infect; 2023 Apr; 86(4):316-328. PubMed ID: 36764393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of OXA-48-like and NDM carbapenemases among carbapenem resistant
    Ghanbarinasab F; Haeili M; Ghanati SN; Moghimi M
    Iran J Microbiol; 2023 Oct; 15(5):609-615. PubMed ID: 37941881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenemase- and Colistin Resistant
    Zhang X; Fang C; Zhang J; Hua W; He R; Zhou M
    Infect Drug Resist; 2022; 15():5315-5320. PubMed ID: 36110130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel variant NDM-11 and other NDM-1 variants in multidrug-resistant Escherichia coli from South India.
    Rahman M; Mukhopadhyay C; Rai RP; Singh S; Gupta S; Singh A; Pathak A; Prasad KN
    J Glob Antimicrob Resist; 2018 Sep; 14():154-157. PubMed ID: 29656053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant
    Han R; Shi Q; Wu S; Yin D; Peng M; Dong D; Zheng Y; Guo Y; Zhang R; Hu F;
    Front Cell Infect Microbiol; 2020; 10():314. PubMed ID: 32719751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary.
    Gajdács M; Ábrók M; Lázár A; Jánvári L; Tóth Á; Terhes G; Burián K
    Acta Microbiol Immunol Hung; 2020 Dec; 67(4):209-215. PubMed ID: 33258795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.